Actinium Pharmaceuticals Inc. Submits Proposal To FDA For Phase 3 Blood Cancer Trial
July 15, 2015 at 12:42 PM EDT
Actinium files phase 3 pre-IND meeting for its blood cancer trial to treat patients with its lomab-b drug candidate .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.